Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Gibson

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|June 23, 1998
Butyrylcholinesterase K: an association with dementia with Lewy bodiesA B Singleton, A M Gibson, J A Edwardson, et al.
The Journal of Applied Bacteriology|September 1, 1987
Evaluation of a monoclonal antibody-based immunoassay for detecting type A Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat systemA M Gibson, N K Modi, T A Roberts, et al.
Neuroscience Letters|April 12, 2001
Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodiesA B Singleton, A M Gibson, I G McKeith, et al.
Journal of Clinical Microbiology|August 1, 1994
Application of PCR to a clinical and environmental investigation of a case of equine botulismE A Szabo, J M Pemberton, A M Gibson, et al.
Journal of Medical Genetics|January 20, 2004
No evidence of an association between the T16189C mtDNA variant and late onset dementiaA M Gibson, J A Edwardson, D M Turnbull, et al.
Peptides|July 1, 1988
Removal of Arg1 and Phe22 from CLIP (ACTH18-39) by rodent pituitary and blood peptidasesJ R McDermott, J A Biggins, A I Smith, et al.
International Journal of Food Microbiology|April 4, 2000
The effect of 100% CO2 on the growth of nonproteolytic Clostridium botulinum at chill temperaturesA M Gibson, R C Ellis-Brownlee, M E Cahill, et al.
The Journal of Prevention of Alzheimer'S Disease|December 18, 2020
Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer's DiseaseP Daunt, C G Ballard, B Creese, et al.
Biological Psychiatry|October 1, 1987
A preliminary study of plasma alpha MSH concentrations in depressed patients and normal subjectsB G Charlton, I N Ferrier, A M Gibson, et al.
Journal of Neurochemistry|October 1, 1987
Raised thyrotrophin-releasing hormone, pyroglutamylamino peptidase, and proline endopeptidase are present in the spinal cord of wobbler mice but not in human motor neurone diseaseJ A Court, J R McDermott, A M Gibson, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|June 23, 1998
Butyrylcholinesterase K: an association with dementia with Lewy bodiesA B Singleton, A M Gibson, J A Edwardson, et al.
The Journal of Applied Bacteriology|September 1, 1987
Evaluation of a monoclonal antibody-based immunoassay for detecting type A Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat systemA M Gibson, N K Modi, T A Roberts, et al.
Neuroscience Letters|April 12, 2001
Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodiesA B Singleton, A M Gibson, I G McKeith, et al.
Journal of Clinical Microbiology|August 1, 1994
Application of PCR to a clinical and environmental investigation of a case of equine botulismE A Szabo, J M Pemberton, A M Gibson, et al.
Journal of Medical Genetics|January 20, 2004
No evidence of an association between the T16189C mtDNA variant and late onset dementiaA M Gibson, J A Edwardson, D M Turnbull, et al.
Peptides|July 1, 1988
Removal of Arg1 and Phe22 from CLIP (ACTH18-39) by rodent pituitary and blood peptidasesJ R McDermott, J A Biggins, A I Smith, et al.
International Journal of Food Microbiology|April 4, 2000
The effect of 100% CO2 on the growth of nonproteolytic Clostridium botulinum at chill temperaturesA M Gibson, R C Ellis-Brownlee, M E Cahill, et al.
The Journal of Prevention of Alzheimer'S Disease|December 18, 2020
Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer's DiseaseP Daunt, C G Ballard, B Creese, et al.
Biological Psychiatry|October 1, 1987
A preliminary study of plasma alpha MSH concentrations in depressed patients and normal subjectsB G Charlton, I N Ferrier, A M Gibson, et al.
Journal of Neurochemistry|October 1, 1987
Raised thyrotrophin-releasing hormone, pyroglutamylamino peptidase, and proline endopeptidase are present in the spinal cord of wobbler mice but not in human motor neurone diseaseJ A Court, J R McDermott, A M Gibson, et al.
Pageof 5